Hydrochloric Acid

Hydrochloric Acid

SCHEMBL534401

CCCCCCCCCCCCCCCCC(C)C(C)(C)N.Cl

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 known ✓ P35372 1/20 0.46
SPHK1 Q9NYA1 2/20 0.43
DNM1 Q05193 4/20 0.39
LMNA P02545 2/20 0.38
TP53 P04637 2/20 0.38
CYP2D6 P10635 2/20 0.36
ADH1B P00325 1/20 0.36
ADH1C P00326 1/20 0.36
ADH1A P07327 1/20 0.36
ADH4 P08319 1/20 0.36
ADH7 P40394 1/20 0.36
PLA2G1B P04054 1/20 0.36
PLA2G2A P14555 1/20 0.36
GMNN O75496 1/20 0.36
POLB P06746 1/20 0.36
THPO P40225 1/20 0.36
MTOR P42345 1/20 0.36
BLM P54132 1/20 0.36
KDM4E B2RXH2 1/20 0.36
CYP1A2 P05177 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL136267 1.00 OPRM1 (0.46) OPRM1SPHK1DNM1LMNATP53
Hydrochloric Acid SCHEMBL15823526 1.00 OPRM1 (0.46) OPRM1SPHK1DNM1LMNATP53
Hydrochloric Acid SCHEMBL3101949 1.00 OPRM1 (0.46) OPRM1SPHK1DNM1LMNATP53
Hydrochloric Acid SCHEMBL3104729 1.00 OPRM1 (0.46) OPRM1SPHK1DNM1LMNATP53
Hydrochloric Acid SCHEMBL634994 1.00 OPRM1 (0.46) OPRM1SPHK1DNM1LMNATP53
Hydrochloric Acid SCHEMBL9420650 1.00 OPRM1 (0.46) OPRM1SPHK1DNM1LMNATP53
Hydrochloric Acid SCHEMBL1254112 1.00 OPRM1 (0.46) OPRM1SPHK1DNM1LMNATP53
Hydrochloric Acid SCHEMBL637396 1.00 OPRM1 (0.46) OPRM1SPHK1DNM1LMNATP53
Hydrochloric Acid SCHEMBL5138752 1.00 OPRM1 (0.46) OPRM1SPHK1DNM1LMNATP53
Hydrochloric Acid SCHEMBL8357940 1.00 OPRM1 (0.46) OPRM1SPHK1DNM1LMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 835 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260026506-A1 COMPOSITION FOR DISSOLVING AN OILY COMPOUND IN WATER AFFIX LABS OY (FI) 2026-01-29 US claimed
EP-4561349-A1 COMPOSITION FOR DISSOLVING AN OILY COMPOUND IN WATER Affix Labs Oy (FI) 2025-06-04 EP claimed
CN-119604192-A Composition for dissolving oily compounds in water 阿菲克斯实验室有限公司 2025-03-11 CN claimed
US-20240425746-A1 METHODS AND FORMULATIONS FOR ENHANCED OIL RECOVERY PIRI TECHNOLOGIES, LLC 2024-12-26 US claimed
US-20240191084-A1 ANTIMICROBIAL AND ANTIVIRAL BUILDING PANELS ARMSTRONG WORLD INDUSTRIES, INC. 2024-06-13 US claimed
CN-117886852-A Triethyl phosphate and synthesis process thereof 杭州潜阳科技股份有限公司 2024-04-16 CN claimed
WO-2024023183-A1 COMPOSITION FOR DISSOLVING AN OILY COMPOUND IN WATER AFFIX LABS OY (FI) 2024-02-01 WO claimed
EP-4244302-A1 METHODS AND FORMULATIONS FOR ENHANCED OIL RECOVERY University of Wyoming (US) 2023-09-20 EP claimed
US-20230025277-A1 OLEOPHOBIC FLUOROPOLYMERS AND FIBROUS MATERIALS PREPARED THEREFROM ENTEGRIS, INC. 2023-01-26 US claimed
WO-2023272452-A1 OLEOPHOBIC FLUOROPOLYMERS AND FIBROUS MATERIALS PREPARED THEREFROM ENTEGRIS, INC. (US) 2023-01-05 WO claimed
US-5254273-A Lubricating oil and intercalation compound of metal phosphorus chalcoenide and alkylamine or alkylammonium chloride KYODO YUSHI CO., LTD. (JP) 1993-10-19 US claimed
EP-0477198-A1 METHOD FOR RECOVERING RECOMBINANT PROTEINS. PITMAN MOORE INC (US) 1992-04-01 EP claimed
US-5101018-A Somatotropin, Amine Salt or Quaternary Ammonium Salt INTERNATIONAL MINERALS & CHEMICAL CORP. (US) 1992-03-31 US claimed
WO-1991013122-A1 SUBSTITUTED XANTHENE COMPOUNDS STEADFAST, INCORPORATED (US) 1991-09-05 WO claimed
WO-1990015876-A1 METHOD FOR RECOVERING RECOMBINANT PROTEINS PITMAN-MOORE, INC. (US) 1990-12-27 WO claimed
EP-0151114-B1 ACID BASED VARIABLE VISCOSITY COMPOSITIONS SUCH AS CORROSION AND GREASE REMOVERS AND POLISHERS Lott, Peter F., Dr. (US) 1990-04-04 EP claimed
EP-0272629-A2 Releasing agent and its use AIR PRODUCTS GMBH (DE) 1988-06-29 EP claimed
US-4518519-A POLYVINYLPYRROLIDONE LOTT PETER F 1985-05-21 US claimed
US-3959574-A Biasable member and method for making XEROX CORPORATION (US) 1976-05-25 US claimed
US-3950223-A WATER SOLUBLE AMINO SUGARS, AMINO ACIDS, AND CATIONIC SURFACTANTS AJINOMOTO CO., INC. (JA) 1976-04-13 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260026506-A1 COMPOSITION FOR DISSOLVING AN OILY COMPOUND IN WATER ACHE, CYP51A1, DNER OPRM1 3787/4885SPHK1 256/4885DNM1 1614/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.